Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study
- PMID: 27797989
- PMCID: PMC5073480
- DOI: 10.1136/bmjopen-2016-011539
Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study
Abstract
Objective: The aim of the study was to evaluate awareness of the varicella zoster virus and the acceptability of the newly available herpes zoster (HZ) vaccine in the over 50 years old general population.
Design: The research was observational.
Setting: The study was carried out in Ferrara by administering a questionnaire to patients of the Local Health Authority (LHA), general practitioners (GPs) and Public Health Department outpatient clinics.
Participants: The questionnaire was completed by 1001 residents of Ferrara Province.
Results: Of the respondents, 98% and 95% (57% female) were aware of varicella and HZ, respectively, but 91% were unaware of the HZ vaccine. Nevertheless, 58% declared that they were in favour of vaccination in this regard, and the acceptability of the vaccine was positively affected by: age (p=0.005); knowing someone who had suffered from HZ (p=0.05); being in favour of vaccination in general (p<0.0001); receiving advice to do so from their GP (p<0.0001) and willingness to get vaccinated even on a fee-paying basis (p<0.0001). Indeed, most (73%) respondents were willing to pay to get vaccinated, indicating an ideal cost of €50. Higher education (p=0.04), being in favour of vaccinations in general (p<0.0001) and GP advice (p<0.0001) positively affected this choice. Furthermore, 61% of the participants initially unfavourable (p<0.0001) to this immunisation would change their decision not to vaccinate thanks to their GP's advice.
Conclusions: This study assessed the level of awareness and the attitudes of the population aged over 50 years, highlighting aspects to be focused on in the promotion of the HZ vaccine.
Keywords: Acceptability; Herpes Zoster; Vaccine.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
GG received grants from GlaxoSmithKline Biologicals SA, Sanofi Pasteur MSD, Novartis, Crucell/Janssen, Pfizer and Sequirus for being consultant or taking part in advisory boards, expert meetings, being a speaker or an organiser of congresses/conferences, and acting as investigator in clinical trials.
Similar articles
-
Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.Hum Vaccin Immunother. 2015;11(3):719-26. doi: 10.1080/21645515.2015.1008885. Hum Vaccin Immunother. 2015. PMID: 25785481 Free PMC article.
-
Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly.Vaccine. 2009 Jan 7;27(2):192-6. doi: 10.1016/j.vaccine.2008.10.047. Epub 2008 Nov 7. Vaccine. 2009. PMID: 18996427
-
The barriers and facilitators of herpes zoster vaccination intentions of urban residents in China: a qualitative study.Glob Health Res Policy. 2025 Apr 18;10(1):19. doi: 10.1186/s41256-025-00413-1. Glob Health Res Policy. 2025. PMID: 40247411 Free PMC article.
-
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.BMC Infect Dis. 2017 Mar 15;17(1):213. doi: 10.1186/s12879-017-2198-y. BMC Infect Dis. 2017. PMID: 28298208 Free PMC article. Review.
-
Herpes zoster: vaccination status and virtuous experiences.Minerva Med. 2020 Feb;111(1):4-8. doi: 10.23736/S0026-4806.19.06412-7. Minerva Med. 2020. PMID: 32286762 Review.
Cited by
-
Drivers of and barriers to routine adult vaccination: A systematic literature review.Hum Vaccin Immunother. 2022 Nov 30;18(6):2127290. doi: 10.1080/21645515.2022.2127290. Epub 2022 Oct 5. Hum Vaccin Immunother. 2022. PMID: 36197070 Free PMC article.
-
Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: 10.1177/25151355221084535. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35340552 Free PMC article. Review.
-
Knowledge, Attitudes, and Behaviors of Parents towards Recommended Adult Vaccinations: An Explanatory Survey in the Geographic Area of Naples, Italy.Int J Environ Res Public Health. 2019 Jun 12;16(12):2070. doi: 10.3390/ijerph16122070. Int J Environ Res Public Health. 2019. PMID: 31212739 Free PMC article.
-
Awareness and acceptability of herpes zoster vaccination in people living with HIV.Prev Med Rep. 2025 Jun 16;56:103143. doi: 10.1016/j.pmedr.2025.103143. eCollection 2025 Aug. Prev Med Rep. 2025. PMID: 40606641 Free PMC article.
-
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients.Hum Vaccin Immunother. 2024 Dec 31;20(1):2317595. doi: 10.1080/21645515.2024.2317595. Epub 2024 Mar 19. Hum Vaccin Immunother. 2024. PMID: 38502342 Free PMC article.
References
-
- Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 2014;89:265–87. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical